Sildenafil citrate and blood-pressure-lowering drugs: Results of drug interaction studies with an organic nitrate and a calcium antagonist

American Journal of Cardiology

Volumn 83, Issue 5 A, 1999, Pages 21-28

  Webb, David J ^a   Freestone, Stephen ^a   Allen, Michael J ^b   Muirhead, Gary J ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Inveresk Clinical Research   (United Kingdom)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; NITRATE; SILDENAFIL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG POTENTIATION; DYSPEPSIA; HEADACHE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION;

EID: 0033522244     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00044-2     Document Type: Article

References (20)

1. Boolell M., Allen M.J., Ballard S.A., Gepi-Attee S., Muirhead G.J., Naylor A.M., Osterloh I.H., Gingell C. Sildenafil an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction . Int J Impot Res. 8:1996;47-52.
2. VIAGRA [package insert]. New York, NY: Pfizer Inc, 1998.
3. Andersson K.-E., Wagner G. Physiology of penile erection. Physiol Rev. 75:1995;191-236.
4. Burnett A.L. Role of nitric oxide in the physiology of erection. Biol Reprod. 52:1995;485-489.
5. Burnett A.L. Nitric oxide in the penis physiology and pathology . J Urol. 157:1997;320-324.
6. Rajfer J., Aronson W.J., Bush P.A., Dorey F.J., Ignarro L.J. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 326:1992;90-94.
7. Jeremy J.Y., Ballard S.A., Naylor A.M., Miller M.A.W., Angelini G.D. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol. 79:1997;958-963.
8. Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 338:1998;1397-1404.
9. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., McKinlay J.B. Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study . J Urol. 151:1994;54-61.
10. Haynes W.G., Noon J.P., Walker B.R., Webb D.J. L-NMMA increases blood pressure in man. Lancet. 342:1993;931-932.
11. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012.
12. Vallance P. Control of the human cardiovascular system by nitric oxide. J Hum Hypertens. 10:1996;377-381.
13. Parker J.D., Parker J.O. Nitrate therapy for stable angina pectoris. N Engl J Med. 338:1998;520-531.
14. Jackson G., Benjamin N., Jackson N., Allen M.J. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol. 83:(suppl 5A):1999;13C-20C.
15. Cooper J., Muirhead D., Taylor J., Baker P. Development of an assay for the simultaneous determination of sildenafil (Viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatography. J Chromatogr B. 701:1997;87-95.
16. Parati G., Casadei R., Groppelli A., Di Rienzo M., Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension. 13:1989;647-655.
17. Food and Drug Administration Web site. Available at: http://www.fda.gov/medwatch/safety/1998/viagra.htm. Accessed May 22, 1998.
18. Cappuccio F.P., Markandu N.D., Singer D.R.J., MacGregor G.A. Amlodipine and lisinopril in combination for the treatment of essential hypertension efficacy and predictors of response . J Hypertens. 11:1993;839-847.
19. Morales A., Gingell C., Collins M., Wicker P.A., Osterloh I.H. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res. 10:1998;69-74.
20. Zusman R, Collins M. Effect of sildenafil on blood pressure in men with erectile dysfunction taking concomitant antihypertensive medications (Abstr.) J Am Coll Cardiol 1999; In press.